In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Arthur BauerDepartment of Hematology and Oncology, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.
Annette ArndtInstitute for Pathology und Molecularpathology, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.ORCID 0009-0003-9764-5074 Luisa ReichenbachDepartment of Hematology and Oncology, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.
Niklas GebauerDepartment for Hematology and Oncology, University Hospital Schleswig-Holstein Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.ORCID 0000-0003-0566-4554 Matthias MüllerDepartment of Hematology and Oncology, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.ORCID 0000-0003-0421-2011 Christian NeumannDepartment of Hematology and Oncology, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.ORCID 0000-0001-9513-6805 Chris SchulzDepartment of Neurosurgery, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.
Konrad SteinestelInstitute for Pathology und Molecularpathology, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.ORCID 0000-0002-6549-9848 Raban HellerCentral Clinical Management, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.ORCID 0000-0001-8006-9742 Emil ChteinbergInstitute for Pathology, University Ulm, Albert Einstein Allee 23, 89081 Ulm, Germany.ORCID 0000-0002-9231-9291 Hauke BuschUniversity Cancer Center Schleswig-Holstein (UCCSH), UKSH Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.ORCID 0000-0003-4763-4521 Armin RieckeDepartment of Hematology and Oncology, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.
Axel KünstnerUniversity Cancer Center Schleswig-Holstein (UCCSH), UKSH Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.ORCID 0000-0003-0692-2105 Hanno WitteDepartment of Hematology and Oncology, Bundeswehrkrankenhaus Ulm, Oberer Eselsberg 40, 89081 Ulm, Germany.ORCID 0000-0001-5767-7125 Funding
Bundesministerium für Bildung und Forschung project Outlive Colorectal Cancer Consortium FKZ 01KD2103AGerman Federal Armed Forces 45K3-S-54-2224
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
adenosine pathwaybrain metastasisCD39CD73immunotherapy
Identifiers
PMID41976310
PMCPMC13072088
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390